As of 2024-12-13, the Fair Value of Nektar Therapeutics (NKTR) is -4.56 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.02 USD, the upside of Nektar Therapeutics is -547.25%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -440.70 | -444.40 | -523.80 | -368.20 | -276.06 | -410.63 |
| YoY growth | -164.69% | -0.84% | -17.87% | 29.71% | 25.03% | -25.73% |
| Market Cap (mil) | 188.15 |
| P/E | |
| Forward P/E |
| EPS | -0.91 |
| Avg earnings growth rate | -25.73% |
| TTM earnings | -168.30 |